Open label pilot study of atomoxetine in adults with ADHD and substance use disorder

Journal of Dual Diagnosis

Volumn 6, Issue 3-4, 2010, Pages 196-207

  Adler, Lenard A ^a   Guida, Frank ^b   Irons, Shirley ^a   Shaw, David M ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Odyssey House   (United States)

Author keywords

ADHD; adults; atomoxetine; substance dependence

Indexed keywords

ATOMOXETINE;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; HUMAN; MALE; PILOT STUDY; RATING SCALE; RESIDENTIAL CARE; SIDE EFFECT; STUDENT T TEST; SUBSTANCE ABUSE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; WITHDRAWAL SYNDROME;

EID: 78650574273     PISSN: 15504263     EISSN: 15504271     Source Type: Journal    
DOI: 10.1080/15504263.2010.537224     Document Type: Article

References (34)

1. Adler, L., & Cohen, J. (2004). Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatric Clinics of North America, 27(2), 187-201.
2. Adler, L., Dietrich, A., Reimherr, F. W., Taylor, L. V., Sutton, V. K., Bakken, R., et al. (2006). Safety and tolerability of once versus twice daily atomoxetine in adults with ADHD. Annals of Clinical Psychiatry, 18(2), 107-113.
3. Adler, L. A., Guida, F., Irons, S., Rotrosen, J., & O'Donnell, K. (2009). Screening and imputed prevalence of ADHD in adult patients with comorbid substance use disorder at a residential treatment facility. Postgraduate Medicine, 121(5), 7-10.
4. Adler, L. A., Spencer, T., Brown, T. E., Holdnack, J., Saylor, K., Schuh, K., et al. (2009). Once-daily atomoxetine for adult attention-deficit/ hyperactivity disor-der: A 6-month, double-blind trial. Journal of Clinical Psychopharmacology, 29(1), 44-50.
5. Adler, L. A., Spencer, T., Faraone, S. V., Kessler, R. C, Howes, M., Biederman, J., & Secnik, K. (2006). Validity of pilot adult ADHD self-report scale (ASRS) to rate adult ADHD symptoms. Annals of Clinical Psychiatry, 18(3), 145-148.
6. Adler, L. A., Spencer, T., Faraone, S. V., Reimherr, F. W., Kelsey, D., Michelson, D., & Biederman, J. (2005). Training raters to assess adult ADHD: Reliability of ratings. Journal of Attention Disorders, 8(3), 121-126.
7. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
8. Barkley, R. A., & Cox, D. (2007). A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance. Journal of Safety Research, 38(1), 113-128.
9. Barkley, R. A., Guevremont, D. C, Anastopoulos, A. D., DuPaul, G. J., & Shelton, T. L. (1993). Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: A 3-to 5-year follow-up survey. Pediatrics, 92(2), 212-218.
10. Barkley, R. A., Murphy, K. R., DuPaul, G. I., & Bush, T. (2002). Driving in young adults with attention deficit hyperactivity disorder: Knowledge, performance, adverse outcomes, and the role of executive functioning. Journal of the International Neuropsychological Society, 8(5), 655-672.
11. Barkley, R. A., Murphy, K. R., & Kwasnik, D. (1996). Motor vehicle driving competencies and risks in teens and young adults with attention deficit hyperactivity disorder. Pediatrics, 98(6, Pt. 1), 1089-1095.
12. Biederman, J., Faraone, S. V., Spencer, T. J., Mick, E., & Monuteaux, M. C. (2006). Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community. Journal of Clinical Psychiatry, 67(4), 524-540.
13. Biederman, J., Wilens, T., Mick, E., Faraone, S. V., Weber, W., Curtis, S., et al. (1997). Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. Journal of the American Academy of Child and Adolescent Psychiatry, 36(1), 21-29.
14. Biederman, J., Wilens, T., Mick, E., Milberger, S., Spencer, T. J., & Faraone, S. V. (1995). Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): Effects of ADHD and psychiatric comorbidity. American Journal of Psychiatry, 152(11), 1652-1658.
15. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. (2002). Structured clinical interviewfor DSM-IV-TR Axis I disorders\Patient edition (SCID-I/P). New York: Biometrics Research Department, New York State Psychiatric Institute.
16. Guy, W. (1976). Clinical global impressions. In W. Guy (Ed.), ECDEU assessment manualforpsychopharmacology (Rev. ed., pp. 217-221). Rockville, MD: National Institute of Mental Health.
17. Halikas, J. A., Crosby, R. D., Carlson, G. A., Crea, F., Graves, N. M., & Bowers, L. D. (1991). Cocaine reduction in unmotivated crack users using carbamazepine versus placebo in a short-term, double-blind crossover design. Clinical Pharmacology and Therapeutics, 50(1), 81-95.
18. Heil, S. H., Holmes, H. W., Bickel, W. K., Higgins, S. T., Badger, G. J., Laws, H. F., & Faries, D. E. (2002). Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users. Drug and Alcohol Dependence, 67(2), 149-156.
19. Kessler, R. C, Adler, L., Ames, M., Demler, O., Faraone, S., Hiripi, E., et al. (2005). The World Health Organization Adult ADHD Self-Report Scale (ASRS): A short screening scale for use in the general population. Psychological Medicine, 35(2), 245-256.
20. Kessler, R. C, Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., et al. (2006). The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. American Journal of Psychiatry, 163(4), 716-723.
21. Kessler, R. C, Adler, L. A., Gruber, M. J., Sarawate, C. A., Spencer, T., & Van Brunt, D. L. (2007). Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) Screener in a representative sample of health plan members. InternationalJournal of Methods in Psychiatric Research, 16(2), 52-65.
22. Kollins, S. H., MacDonald, E. K., & Rush, C. R. (2001). Assessing the abuse potential of methylphenidate in nonhuman and human subjects: A review. Pharmacology, Biochemistry and Behavior, 68(3), 611-627.
23. Leon, A. C, Olfson, M., Portera, L., Farber, L., & Sheehan, D. V. (1997). Assessing psychiatric impairment in primary care with the Sheehan Disability Scale. International Journal of Psychiatry in Medicine, 27(2), 93-105.
24. Levin, F. R., Mariani, J. J., Secora, A., Brooks, D., Cheng, W. Y., Bisaga, A., et al. (2009). Atomoxetine treatment for cocaine abuse and adult attention-deficit hyperactivity disorder (ADHD): A preliminary open trial. Journal of Dual Diagnosis, 5(1), 41-56.
25. Mariani, J. J., & Levin, F. R. (2007). Treatment strategies for co-occurring ADHD and substance use disorders. American Journal of Addictions, 16(Suppl. 1), 45-54; quiz 55-46.
26. McGough, J. J., Smalley, S. L., McCracken, J. T., Yang, M., Del'Homme, M., Lynn, D. E., & Loo, S. (2005). Psychiatric comorbidity in adult attention deficit hyperactivity disorder: Findings from multiplex families. American Journal of Psychiatry, 162(9), 1621-1627.
27. Mezinskis, J. P., Honos-Webb, L., Kropp, F., & Somoza, E. (1998). The measurement of craving. Journal of Addictive Diseases, 20(3), 67-85.
28. Michelson, D., Adler, L., Spencer, T., Reimherr, F. W., West, S. A., Allen, A. J., et al. (2003). Atomoxetine in adults with ADHD: Two randomized, placebo-controlled studies. Biological Psychiatry, 53(2), 112-120.
29. Schubiner, H. (2005). Substance abuse in patients with attention-deficit hyperactivity disorder: Therapeutic implications. CNS Drugs, 19(8), 643-655.
30. Spencer, T. J., Adler, L. A., Qiao, M., Saylor, K. E., Brown, T. E., Holdnack, J. A., et al. (2010). Validation of the Adult Investigator Symptom Rating Scale (AISRS). Journal of Attention Disorders, 14(1), 57-68.
31. Vitiello, B. (2001). Long-term effects of stimulant medications on the brain: Possible relevance to the treatment of attention deficit hyperactivity disorder. Journal of Child and AdolescentPsychopharmacology, 11(1), 25-34.
32. Wilens, T. E., Adler, L. A., Adams, J., Sgambati, S., Rotrosen, J., Sawtelle, R., et al. (2008). Misuse and diversion of stimulants prescribed for ADHD: A systematic review of the literature. Journal of the American Academy of Child and Adolescent Psychiatry, 47(1), 21-31.
33. Wilens, T. E., Adler, L. A., Weiss, M. D., Michelson, D., Ramsey, J. L., Moore, R. J., et al. (2008). Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders. Drug and Alcohol Dependence, 96(1-2), 145-154.
34. Wilens, T. E., Biederman, J., & Mick, E. (1998). Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD. American Journal of Addictions, 7(2), 156-163.